Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$9.87

Avg closing price
Price range

4 Jefferies Group Eagle Pharmaceuticals Trades

The first Eagle Pharmaceuticals trade was made in Q1 2023. Since then Jefferies Group bought shares one more times and sold shares on two occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in Eagle Pharmaceuticals anymore.

Avg closing price
Price range
Sold -119 Thousand shares Q1 2024
Avg closing price $5.49
Price range $4.26 - $6.51
New holding (+119 Thousand shares) Q4 2023
Avg closing price $9.87
Price range $4.63 - $15.21
Sold -38.9 Thousand shares Q2 2023
Avg closing price $23.72
Price range $17.74 - $31.87
New holding (+38.9 Thousand shares) Q1 2023
Avg closing price $29.69
Price range $25.06 - $34.09

News about Eagle Pharmaceuticals Inc and Jefferies Group

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!